Tehran: The first study of the safety and effectiveness of the domestically developed Corona Virus Vaccine in Iran started on Tuesday and dozens of people are to be planted in this country badly affected by the infection. . Shifa PharmaMed, a state-owned pharmaceutical association in Iran, has developed the vaccine and is the first vaccine to reach the level of human testing.
President Hasan Ruhani has said that Iran is partnering with another country to produce another vaccine that could be tested on human participants in February. He did not give more information about this. Iran has been worst affected by the Covid-19 epidemic in West Asia where more than 1.2 million people have been infected so far and about 55,000 people have died from the infection.
In the first phase clinical trial, a total of 56 participants will be given two doses of the Iran-made vaccine within two weeks. This information was given by Hamid Hussaini associated with the test. He informed that the results will be announced about one month after the second dose.